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Copyright © 2016 D. Załuski and R. Kuźniewski.This is an open access article distributed under theCreativeCommonsAttribution
License, which permits unrestricted use, distribution, and reproduction in anymedium, provided the originalwork is properly cited.
Neurodegenerative diseases are one of the most occurring diseases in developed and developing countries. The aim of this work
focused on the screening of the natural inhibitors of AChE and BuChE and antioxidants in Eleutherococcus species. We found that
the ethanol extracts of E. setchuenensis and E. sessiliflorus showed the strongest inhibition towards AChE (IC50: 0.3 and 0.3mg/mL,
resp.). Among chloroform extracts, the most active appeared to be E. gracilistylus (IC50: 0.37mg/mL). In turn, the ethanol extract of
E. henryi inhibited the strongest BuChEwith IC50 value of 0.13mg/mL. Among chloroform extracts,E. gracilistylus,E. setchuenensis,
and E. sessiliflorus appeared to be the strongest with IC50 values of 0.12, 0.18, and 0.19mg/mL. HPTLC screening confirmed the
presence of inhibitors in extracts. All extracts exhibited anti-DPPH∗ activity and single antioxidants have been identified. To the
best of our knowledge, no information was available on this activity of compounds in Eleutherococcus. These studies provide a
biochemical basis for the regulation of AChE and BuChE and encourage us to continue isolation of active compounds.
1. Introduction
Acetylcholinesterase (AChE) and butyrylcholinesterase
(BuChE) take part in the termination of nerve impulse
transmission at the cholinergic synapses by rapid hydrolysis
of acetylcholine (ACh). Excessive hydrolysis of acetylcholine
(ACh) and butyrylcholine (BCh) is one of the causes of
neurodegenerative diseases, such as Alzheimer’s disease
(AD), ataxia, or Parkinson’s disease.
Alzheimer’s disease (AD) is the most common cause of
senile dementia in later life. This disease affects from 4%
to 10% of the world’s population over the age of 65 years.
According to the statistics, in Poland, over 250 000 people
suffer from AD, while in the United States the number of AD
sufferers reached 4million, and this number increases every
single year. Inhibition of these enzymes serves as a strategy for
the treatment of Alzheimer’s disease (AD), senile dementia,
ataxia, myasthenia gravis, and Parkinson’s disease [1–4].
Many secondary plant metabolites and several synthetic
substances exhibit anti-AChE and anti-BuChE activity; nev-
ertheless, their use is still restricted. Currently used licensed
drugs (tacrine, donepezil, and rivastigmine) show selectivity
towards one of the two enzymes, which leads to a compensa-
tionmechanism and increased activity of the other one. It has
been found that these compounds have adverse effects includ-
ing gastrointestinal disturbances and problems associated
with bioavailability. Besides, tacrine is hepatotoxic, and hep-
atoprotective drugs have to be used simultaneously. Rivastig-
mine (Exelon) was licensed for use in Europe in 2000. It is
well known that synthetic inhibitors just slow the progress of
the disease but do not cure it [5, 6].
One of the most intensively studied areas of research has
been the investigation of plants with an anticholinesterase
action. The increasing incidence of AD has given fresh
impetus to the search for novel anti-AChE and anti-BuChE
agents. New lead compounds are also needed in the field of
pharmacotherapy, phytotherapy, and natural products.
A new source of AChE and BuChE inhibitors can be sec-
ondary metabolites present in Eleutherococcus species, which
are native to Eastern Asia, the Himalayas, and Northeastern
Russia.Themain secondary metabolites are polyphenols that
include eleutherosides B, B1, E, and E1 and are thought to be
Hindawi Publishing Corporation
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 4135135, 7 pages
http://dx.doi.org/10.1155/2016/4135135
2 Oxidative Medicine and Cellular Longevity
the pharmacologically most active constituents [7–12]. These
species have been used in old Chinese pharmacy for improv-
ing human’s physical and mental efficiency. People used
to believe that they improve cognitive functions, such as
learning or memory; thus, scientists now take into account
the use of Eleutherococcus in neurodegenerative ailments.
Only few papers describing a weak inhibitory effect
of E. senticosus on the regeneration of neuritis damaged
by amyloid 𝛽(25–35) have been found. The authors have
suggested that E. senticosus may be a candidate useful for
developing therapeutic drugs for Alzheimer’s disease. But
authors have not provided any explanation for the possible
mechanism of the extract’s action and the influence on
AChE and BuChE activity. The studies of the other research
group showed that E. senticosus improves mental process
in rats and reduces hippocampal CA1 neuronal death [13,
14]. Nevertheless, no further information on the inhibitory
activity of remaining species (E. setchuenensis, E. divaricatus,
E. henryi, E. sessiliflorus, and E. gracilistylus) towards AChE
and BuChE has been found.
On the basis of Załuski’s previous studies, it is concluded
that these plants are a very promising source of biologically
active substances. They inhibit metalloproteinases (MMPs,
belonging to the hydrolase enzyme family, like AChE and
BuChE) and neutralize free radicals. It was established that
MMPs and free radicals take part in the etiopathogenesis of
Alzheimer’s disease as well. Some authors have reported on
the damaging effects of ROS on neurones and on PD, AD,
and ALS development. The oxidative stress is involved in the
propagation of cellular injury that leads to neuropathology
[15, 16].
The discovery of new inhibitors of AChE and BuChE is a
highly attractive target both scientifically and commercially;
for these reasons, there is a need to examine anti-AChE and
anti-BuChE activity ofEleutherococcus species. To our knowl-
edge, there are no such phytochemical reports concerning
these cultivars. As part of a program to search for bioactive
constituents from Eleutherococcus species, this study was
focused on the establishment of anti-AChE and anti-BuChE
activities of six Eleutherococcus species and aimed to discuss
the possible antienzymatic mechanism and the structure-
activity relationship.The work aimed at searching for antiox-
idants as well.
2. Materials and Methods
2.1. Standards and Reagents. Physostigmine, Ellman’s rea-
gent (DTNB, 5,5󸀠-dithiobis(2-nitrobenzoic acid)), ATCh
(acetylthiocholine iodide), BTCh (S-butyrylthiocholine iod-
ide), AChE (acetylcholinesterase, Electrophorus electricus),
BuChE (humanplasma butyrylcholinesterase), sodiumphos-
phate buffer, pH 7.0, and DPPH (2,2-diphenyl-1-picryl-
hydrazyl) were obtained from Sigma-Aldrich. Ethanol was
obtained from POCH (Lublin, Poland). All other reagents
were of analytical grade.
2.2. Plant Material. The roots of E. senticosus (Rupr. et
Maxim.) Maxim., E. divaricatus (Siebold et Zucc.) S. Y. Hu,
E. setchuenensis (Harms) Nakai, E. sessiliflorus (Rupr. &
Maxim.) S. Y. Hu, E. gracilistylus (W. W. Smith) S. Y. Hu,
and E. henryiOliv. were collected at the arboretum in Rogów
(Poland) in October 2015 (voucher specimen numbers: ES01,
ED02, ESetch03, ESes04, EG05, and EH06). All plant samples
were deposited at the Department of Pharmacognosy, Col-
legiumMedicum, Jagiellonian University, Cracow, Poland.
2.3. Dried Material Extraction with 75% Ethanol. The air-
dried roots (5 g each) were soaked in 50mL 75% ethanol for
24 h. Next, the samples were subjected to triple UAE type
extraction (ultrasonic bath, Polsonic, Warsaw, Poland) using
1 × 50mL and 2 × 25mL of 75% ethanol. The extraction was
performed at room temperature for 15min for each cycle.
Finally, 100mL of each extract was obtained. The solvents
were dried with an evaporator under vacuum conditions at
45∘C and subjected to lyophilisation.
2.4. Dried Material Extraction with Chloroform. The roots
were extracted in the same way as extraction with 75%
ethanol using chloroform.
2.5. Antienzymatic Studies: Antiacetylcholinesterase and Anti-
butyrylcholinesterase Activities. The inhibition of AChE and
BuChE was determined by the spectrophotometric method
of Ellman et al. [17], and absorbance was measured on a
multidetection BioTek spectrophotometer.The enzyme activ-
ity was 5U/mg protein, and concentration of ATCh and
BTChwas 15mmol, DTNB (0.15mmol).The extracts concen-
trations were 0.1, 0.5, 1.0, and 1.5mg/mL in 10%water ethanol
solution. The final concentrations in the reaction’s mixture
were 2.2, 11, 22, and 33 𝜇g/0.195mL. Physostigmine was used
as positive control at the following concentrations: 2, 3, 4, 15,
30, and 40 𝜇g/0.195mL. Every assay was done in triplicate.
2.6. HPTLC Screening for Inhibitors of AChE and BuChE:
Direct Bioautography (DB) Technique. HPTLC was per-
formed using the method described by Załuski et al. [12].
Si60 HPTLC F254 plates and the following mobile phases were
used: chloroform :methanol : water 70 : 30 : 4 v/v/v for the
ethanol extracts and chloroform : diethyl ether 1 : 1 v/v for the
chloroform extracts.The plates were developed for a distance
of 90mm. After drying at room temperature, the plates were
dipped into the solution of AChE or BuChE (5 s) and next
into Ellman’s reagent, redried, and incubated for 30min at
37∘C in humid atmosphere. Subsequently, the chromatoplates
were immersed for 5 s in the dipping solution of substrates
(acetylthiocholine). After 3min, white spots for AChE and
BuChE inhibiting compounds should be detected on a yellow
(in Ellman’s reaction) background. The enzyme activity was
5U/mg protein, and the concentration of ACh and BuCh was
15mmol, DTNB (0.15mmol).
2.7. HPTLC Screening for Antioxidants: Direct Bioautography
(DB) Technique. TLC was done according to the method of
Załuski et al. [12]. Briefly, TLC was performed on 10 cm ×
20 cm glass Si60 HPTLCF254 plates using chloroform :meth-
anol : water 70 : 30 : 4 v/v/v for the ethanol extracts and
chloroform : diethyl ether 1 : 1 v/v for the chloroform extracts.
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The plate was developed for a distance of 90mm. The plate
was dried at room temperature for 20min. After this time,
the plate was immersed into 0.5% DPPH solution for 5 sec.
Active compounds appeared as yellow-white spots against a
purple background. White spots were visualized under day
light after 1 min, 30min, 1 h, 2 h, 5 h, 10 h, and 24 h.
2.8. Statistical Analysis. Determinations were performed in
triplicate.The obtained data were subjected to statistical anal-
ysis using Statistica 7.0. (StatSoft, Cracow). The evaluations
were analyzed for one-factor variance analysis. Statistical
differences between the treatment groups were estimated by
Spearman’s (𝑅) and Pearson’s (𝑟) test. All statistical tests were
carried out at a significance level of 𝛼 = 0.05.
3. Results and Discussion
3.1. Antienzymatic Activity. Various studies were performed
concerning anticholinesterase activity of plant extracts or
isolated compounds; however, up to now, most of the studies
were focused on anti-AChE activity, not BuChE. Some of
them are used to minimize the symptoms of neurodegen-
erative disorders, such as AD. Presently, several referenced
natural acetylcholinesterase inhibitors are known, including
physostigmine, galantamine, and huperzine A. The best
known natural inhibitor of AChE is pyrroloindole alkaloid
physostigmine isolated from Physostigma venenosum. Unfor-
tunately, its use is limited due to poor intestinal absorption in
humans. Another alkaloid, galantamine (Reminyl), isolated
from Galanthus nivalis and Leucojum vernum is the additive
to drugs used for the treatment of AD and was also licensed
for use in early stages of AD in 2001.Their ingredients include
plants extracts or pure isolates. A large number of alkaloids
have been found to inhibit in vitroAChE. Studies on a variety
of alkaloids have been performed focusing mainly on AChE
activity, not BuChE. However, BuChE plays an important
role as AChE, and the inhibition of just AChE can lead to
a compensation mechanism and increased activity of the
other one [6, 18]. Therefore, there is a need to search for
inhibitors not only of AChE, but also of BuChE. Apart from
enzymes activity, the second factor having an impact on
neurodegenerative diseases is oxidative stress, which leads to
neuronal damage.
In ancient times, people used to believe that Eleutherococ-
cus species, especially E. senticosus, may have an impact on
prevention of memory impairment or treatment of memory
disorders. To give these observations a scientific basis, studies
in this work aimed at the searching for both inhibitors
AChE and BuChE and antioxidants in 12 extracts of six
Eleutherococcus species (polar and nonpolar constituents).
The IC50 values for extracts measured by the microplate
assay are shown in Table 1. In order to compare the antienzy-
matic activities of the extracts analyzed, physostigmine was
used as the standard compound because of its well recognized
activity. Physostigmine inhibited AChE in a dose-dependent
way and 100% of inhibition was observed at concentration
30 𝜇g/195 𝜇L of the reaction mixture with IC50 value of 5 𝜇g.
The ethanol extracts of E. setchuenensis and E. sessiliflorus
showed the strongest inhibition towards AChE (IC50: 0.3
Table 1: IC50 values for extracts (mg/mL). NA: not active.
Species 75% ethanol Chloroform
AChE BuChE AChE BuChE
E. senticosus 0.46 ± 0.04 0.73 ± 0.1 0.75 ± 0.08 0.71 ± 0.08
E. divaricatus 0.94 ± 0.09 0.54 ± 0.04 NA 1.68 ± 0.3
E. setchuenensis 0.3 ± 0.06 0.95 ± 0.2 1.08 ± 0.1 0.18 ± 0.01
E. sessiliflorus 0.3 ± 0.06 0.59 ± 0.04 NA 0.19 ± 0.01
E. henryi 1.75 ± 0.1 0.13 ± 0.02 NA 1.21 ± 0.2
E. gracilistylus 0.41 ± 0.02 1.22 ± 0.3 0.37 ± 0.05 0.12 ± 0.04
and 0.3mg/mL, resp.); among chloroform extracts, the most
active appeared to be E. gracilistylus (IC50: 0.37mg/mL).
In turn, the ethanol extract of E. henryi was the strongest
inhibitor towards BuChE with IC50 value of 0.13mg/mL.
Among chloroform extracts, E. gracilistylus, E. setchuenensis,
and E. sessiliflorus appeared to be the strongest with IC50
values of 0.12, 0.18, and 0.19mg/mL. According to Vinutha et
al., plant extracts with an anti-AChE activity can be classified
into 3 groups: potent group (>50% inhibition), moderate
group (30–50% inhibition), and low activity group (<30%
inhibition) [19].
Plant-based inhibitors of AChE and BuChE have been
found in different plant families, such asMalvaceae, Rutaceae,
Asteraceae, Fumariaceae, Papaveraceae, Lamiaceae, or Coni-
feraceae. According to scientific reports, some species used
in traditional European medicine demonstrate inhibitory
activity towards both AChE and BuChE. In screening studies,
12 species of plants have been used as remedies for the central
nervous system. Of the 24 plant extracts (methanol and
hexane), it was found that Arnica chamissonis Less. subsp.
foliosa (Asteraceae) and Ruta graveolens L. (Rutaceae) had
significant dose-dependent inhibition in the range between
29 and 88𝜇g/mL (IC50 dose). But this effect was less than of
the references galantamine and physostigmine. Other species
have not had any significant AChE and BuChE inhibitory
activity. Comparing the results obtained in this work to those
cited above, it may be concluded that the chloroform extract
from the roots of E. setchuenensis, E. sessiliflorus, and E.
gracilistylus exhibited similar activity, towards BuChE, to the
hexane extract from the herb of Ruta graveolens and the
flowers of Arnica chamissonis. The 50% of inhibition was
observed for the extract concentrations of 61 and 88𝜇g/mL,
respectively. In turn, themethanolic extracts from the herb of
Ruta graveolens and the flowers ofArnica chamissonis showed
stronger inhibition towards AChE than some Eleutherococcus
species (IC50: 34 and 29 𝜇g/mL, resp.) [20]. The results of
other studies have shown that from 180medicinal plants only
flavonoids isolated from Agrimonia pilosa Ledeb. inhibited
AChE significantly [21]. Based on the results of already
published studies, of 32 tested plants, the methanolic extracts
from the roots of Stephania suberosa (L. L. Forman) and
Tabernaemontana divaricata L. have shown high inhibitory
activity, above 90%, at concentration of 0.1mg/mL. In turn,
the extracts from stems of Piper interruptum Opiz., seeds
of Piper nigrum L., rootbarks of Butea superba Roxb., and
roots of Cassia fistula L. showed 50–65% inhibitory activity
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Table 2: Comparison of 𝑅𝑓 values and a number of compounds for free radical scavenging HPTLC fingerprints for the ethanol extracts.
Sample 𝑅𝑓 Number of compounds
0.18 0.54 0.61 0.66 0.70 0.76 0.79 0.82
E. senticosus + + + + + 5
E. divaricatus + + + + + 5
E. setchuenensis + + + + + + + 7
E. sessiliflorus + + + + + 5
E. henryi + + + + + + + + 8
E. gracilistylus + + + + + + + + 8
on AChE at concentration of 0.1mg/mL [22]. Biju et al.
reported on anti-AChE activity of the ethanol extracts from
Baliospermum montanum, Humboldtia brunonis Wall. var.
raktapushpa, and Pittosporum viridulum. The IC50 values
obtained in this study were a little bit lower than those
obtained in the presented work (137.5, 105.7, and 128.3𝜇g/mL
for Baliospermum montanum, Humboldtia brunonis, and
Pittosporum viridulum, resp.) [23]. The latest studies on
the inhibition of AChE and BChE by the ethanol extracts
from the leaves, stems, and flowers of Euphorbia characias
subsp. characias revealed a weak effect with the IC50 values
in the range between 0.6 and 5.8mg/mL for AChE and
0.3 and 1.2 for BuChE, respectively. The IC50 values were,
in some cases, ten orders of magnitude higher compared
to the results obtained in this report [24]. According to
Kaufmann et al., the methanolic extracts from Berberis bealei
and Phellodendron chinense showed low IC50 values towards
AChE (34.1 and 8.03mg/mL, resp.). Despite the fact that
these plants contain the alkaloids berberine, coptisine, and
palmatine as the predominant compounds, their activity was
weaker in comparison to the obtained results [25].The AChE
and BuChE inhibitory activity of the roots, leaves, and stem
of Jatropha gossypifolia has been described. It appeared that
the leaves ethyl acetate extract and the roots dichloromethane
extract inhibited AChE the strongest with IC50 values 95.7
and 176.3 𝜇g/mL. The roots dichloromethane extract inhib-
ited BuChE with IC50 value 77.6𝜇g/mL [26]. Taking into
consideration anti-AChE and anti-BuChE activities of plants
extracts, some authors state that such an activity is dependent
on all compounds which act synergistically. Therefore, plant
extracts are very often used alone or as a combination with
synthetic drugs to reduce side effects ormaximize therapeutic
outcomes.
In the next step, the bioautography test was used to
identify single potential inhibitors. The extracts were devel-
oped on HPTLC plates with the solvent system chloroform :
methanol : water 70 : 30 : 4 v/v/v for the ethanol extracts and
chloroform : diethyl ether 1 : 1 v/v for the chloroform extracts.
The use of TLC screening for plant-based enzyme inhibitors
is a rapid method and is free of disturbances due to the
solvent. The AChE and BuChE inhibiting spots seen after
spraying the substrate and enzyme are shown in Figures 1 and
2. All extracts have had AChE and BuChE inhibitors, which
appeared as white spots on a pale yellow background. The
same compounds have been identified as inhibitors of AChE
andBuChE in the ethanol extracts at the𝑅𝑓 value as indicated
Table 3: Comparison of 𝑅𝑓 values and a number of compounds
for free radical scavenging HPTLC fingerprints for the chloroform
extracts.
Sample 𝑅𝑓 Number ofcompounds0.33 0.52 0.62 0.70
E. senticosus + + + + 4
E. divaricatus + + + + 4
E. setchuenensis + + + 3
E. sessiliflorus + + + 3
E. henryi + + + 3
E. gracilistylus + + + 3
in Figure 1. Each of the ethanol extracts had 4 inhibitors with
𝑅𝑓 values 0.15, 0.19, 0.52, and 0.72 for AChE and 0.15, 0.17,
0.38, and 0.77 for BuChE. Considering chloroform extracts,
5 compounds in each extract have been identified to be
potential inhibitors of AChE (𝑅𝑓 values 0.13, 0.27, 0.48, 0.66,
and 0.78) andBuChE (𝑅𝑓 values 0.19, 0.39, 0.4, 0.53, and 0.70).
3.2. HPTLC-DB of Antioxidants. Since many of the con-
stituents of herbal extracts possess an antioxidative capacity,
it is believed that this property may be involved, at least in
part, in the antineurodegenerative mechanism of the herbal
extract. The second part of the experiment was focused on
the chromatographic identification of DPPH∗ scavengers,
based partially on the fingerprinting conditions and results
obtained by Załuski et al. [12]. The results are presented in
Figures 3 and 4, as well as in Tables 2 and 3. Compounds that
exhibit antiradical potential show up as yellow spots against
a purple background. We observed the plates after 1 min,
30min, 1 h, 2 h, 5 h, 10 h, and 24 h from the time of immersion
of the plate in 0.5% DPPH∗ solution. After 1min, the ethanol
extracts showed areas of activity on high 𝑅𝑓 of 0.18 and 0.54.
The compound at 𝑅𝑓 0.18 appeared as a strong-yellow spot,
which correlates with its high anti-DPPH∗ activity. An addi-
tional yellow-coloured compound was observed to migrate
at 𝑅𝑓 of 0.61 and 0.7. Three other yellow spots at 𝑅𝑓 values of
0.66, 0.79, and 0.82 appeared after 10 h. With all the inves-
tigated extracts, the richest in antioxidants are of E. henryi
and E. gracilistylus (8 compounds). The results for all species
remain in good agreement with the data referring to the spec-
trophotometricDPPH∗ assaymethod. Załuski et al. exhibited
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Figure 1: Screening of ethanol extracts of Eleutherococcus for AChE (a) and BuChE (b) inhibitors using the HPTLC assay method. White
spots, corresponding to 𝑅𝑓 values, on the yellow background represent the inhibition. (1) E. senticosus, (2) E. divaricatus, (3) E. setchuenensis,
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Figure 2: Screening of chloroform extracts of Eleutherococcus for AChE (a) and BuChE (b) inhibitors using the HPTLC assay method.White
spots, corresponding to 𝑅𝑓 values, on the yellow background represent the inhibition. (1) E. senticosus, (2) E. divaricatus, (3) E. setchuenensis,
(4) E. sessiliflorus, (5) E. henryi, and (6) E. gracilistylus.
good radical scavenging activity of the ethanol extracts with
EC50 values between 1.2 and 3.5mg/mL [11].
Taking into account the speed of DPPH∗ decolourization
by chloroform extracts, the differences have been noticed.
Because of the presence of nonpolar compounds, the chloro-
form extracts exhibited a smaller number of inhibition zones.
After 1min, the extracts showed areas of activity on high
𝑅𝑓 of 0.33, 0.52, 0.62, and 0.7. In all the analyzed species,
compounds at 𝑅𝑓 values of 0.52, 0.62, and 0.7 were detected.
Among them, the compound at 𝑅𝑓 value of 0.62 appeared as
the most intensive yellow band.
3.3. Chemical Backgrounds of Anti-AChE, Anti-BuChE, and
Antioxidant Activity of the Analyzed Extracts. This work has
been a continuation of the work on phytochemistry and
bioactivity of Eleutherococcus species since 2008. The chem-
ical profile of the species includes mainly polyphenols, of
which the most abundant are eleutherosides B, E, and E1.
This group of compounds is thought to be the most pharma-
cologically active. In Załuski’s previous studies on Eleuthe-
rococcus, it was revealed that the analyzed species contain
eleutherosides B, E, and E1, even in a larger amount thanwhat
the Polish or European Pharmacopoeia requires. According
to the Polish Pharmacopoeia monograph, the root of E. sen-
ticosus should contain minimum 0.08% for the sum of eleu-
theroside B and eleutheroside E. On the basis of the HPTLC-
densitometric assay, the amount of eleutheroside B ranged
from 0.08 to 0.34%; that of eleutheroside E from 0.05 to










Figure 3: Screening of ethanol extracts of Eleutherococcus for anti-
DPPH∗ scavengers using the HPTLC assay method. Yellow spots,
corresponding to𝑅𝑓 values, on the purple background represent the
inhibition. (1)E. senticosus, (2)E. divaricatus, (3)E. setchuenensis, (4)







Figure 4: Screening of chloroform extracts of Eleutherococcus for
anti-DPPH∗ scavengers using the HPTLC assay method. Yellow
spots, corresponding to 𝑅𝑓 values, on the purple background
represent the inhibition. (1) E. senticosus, (2) E. divaricatus, (3) E.
setchuenensis, (4) E. sessiliflorus, (5) E. henryi, and (6) E. gracilistylus.
0.13%; and that of eleutheroside E1 from 0.02 to 0.09%.
Another compound is (+)-sesamin, which was isolated and
identified by means of GC-MS, 1H- and 13C-NMR, and two-
dimensional NMR experiments (HMQC,HMBC, COSY, and
DEPT) [10, 27].
The second group of compounds present in the roots of
Eleutherococcus species are essential oil and aroma compo-
nents. (E,E)-Farnesol, an acyclic sesquiterpene alcohol, was
the major constituent up to 43.6%, followed by 𝛼-pinene
(18.8%) and pentadecanoic acids (12.3%), [28].
All above compounds contain in their structure the
chemical groups that can interact with the active site of AChE
and BuChE and can scavenge free radicals. They can act as
chelators of metal ions playing as cofactors for an enzyme
activity. The next possible mechanism is the interactions
between active groups of inhibitors and amino acids of the
active site of enzymes. However, further detailed studies on
the mechanism of inhibition will provide reliable results.
In case of anti-DPPH∗ activity, Załuski at el.’s previous
studies revealed that, in this activity, eleutheroside E1 can
be involved. This results from its molecular structure that
demonstrates the one free OH group in the phenyl ring and
four methoxy groups (two in each aromatic ring). This was
called “Załuski’s eleutheroside hypothesis” [9].
4. Conclusion
These basic studies on compounds present in Eleutherococcus
species contribute to the development of general knowledge
about plant-based drugs. The study confirms confirms the
rightness of the traditional use of these species in preven-
tion or treatment of memory impairment and gives useful
information for further purifying steps to dereplicate active
compounds. Further, more detailed studies will be done on
spectral identification of isolates and in in vivomodels.
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